The Muscular Dystrophy Association (MDA) will combine clinical and scientific conferences, a first, establishing an exciting and forward thinking gathering for both clinicians and investigators from across the United States.  Experts from academia, private practice, government and industry—all focused on neuromuscular disease—will join this inaugural gathering themed “Progress in Motion.”  The event will be held April 14-17, 2019 at the Hyatt Regency Orlando.  U.S. Food and Drug Administration’s Janet Woodcock to deliver the keynote speech.


Pin It on Pinterest